Premium
Cocrystal Pharma Inc (COCP)
NASDAQ
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. The company employs structure-based technologies and Nobel Prize-winning expertise to create first... Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. The company employs structure-based technologies and Nobel Prize-winning expertise to create first-and best-in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI). Show more
Data show favorable safety and tolerability with dosing up to 800 mg for 10 daysPlans to initiate human challenge study in 2025 in norovirus-infected subjects BOTHELL, Wash., Jan. 08, 2025...
Data support favorable safety and tolerability profile with no serious adverse events (SAEs) or study-related drug discontinuationsEnrollment to be extended due to low influenza infection among...
BOTHELL, Wash., Nov. 13, 2024 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) (“Cocrystal” or the “Company”) reports financial results for the three and nine months ended September 30...
The Company’s antiviral candidate for seasonal and pandemic influenza shows in vitro activity against the avian influenza A PB2 protein, whereas current influenza vaccines offer no protection...
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.0613 | 2.99024390244 | 2.05 | 2.1749 | 1.88 | 29870 | 1.98480062 | CS |
| 4 | -0.5287 | -20.0265151515 | 2.64 | 3.26 | 1.88 | 92570 | 2.39342813 | CS |
| 12 | 0.3013 | 16.6464088398 | 1.81 | 3.26 | 1.65 | 47564 | 2.2825591 | CS |
| 26 | -0.1987 | -8.60173160173 | 2.31 | 3.26 | 1.6 | 30546 | 2.15739212 | CS |
| 52 | 0.6413 | 43.6258503401 | 1.47 | 3.26 | 1.325 | 27110 | 2.10346467 | CS |
| 156 | -4.0663 | -65.8232970733 | 6.1776 | 7.5588 | 1.325 | 86964 | 4.38933001 | CS |
| 260 | -6.4207 | -75.2543366151 | 8.532 | 49.2 | 1.325 | 2050865 | 18.87010914 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
